Revvity Income from Continuous Operations 2010-2025 | RVTY
Revvity annual/quarterly income from continuous operations history and growth rate from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- Revvity income from continuous operations for the quarter ending June 30, 2025 was $0.055B, a 23.94% decline year-over-year.
- Revvity income from continuous operations for the twelve months ending June 30, 2025 was $0.279B, a 41.21% increase year-over-year.
- Revvity annual income from continuous operations for 2024 was $0.283B, a 57.7% increase from 2023.
- Revvity annual income from continuous operations for 2023 was $0.18B, a 64.99% decline from 2022.
- Revvity annual income from continuous operations for 2022 was $0.513B, a 42.36% decline from 2021.
| Revvity Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $283 |
| 2023 | $180 |
| 2022 | $513 |
| 2021 | $889 |
| 2020 | $631 |
| 2019 | $228 |
| 2018 | $237 |
| 2017 | $157 |
| 2016 | $216 |
| 2015 | $189 |
| 2014 | $130 |
| 2013 | $174 |
| 2012 | $71 |
| 2011 | $1 |
| 2010 | $139 |
| 2009 | $73 |
| Revvity Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-06-30 | $55 |
| 2025-03-31 | $42 |
| 2024-12-31 | $88 |
| 2024-09-30 | $93 |
| 2024-06-30 | $73 |
| 2024-03-31 | $29 |
| 2023-12-31 | $64 |
| 2023-09-30 | $32 |
| 2023-06-30 | $59 |
| 2023-03-31 | $25 |
| 2022-12-31 | $97 |
| 2022-09-30 | $70 |
| 2022-06-30 | $162 |
| 2022-03-31 | $184 |
| 2021-12-31 | $156 |
| 2021-09-30 | $108 |
| 2021-06-30 | $246 |
| 2021-03-31 | $379 |
| 2020-12-31 | $283 |
| 2020-09-30 | $177 |
| 2020-06-30 | $137 |
| 2020-03-31 | $34 |
| 2019-12-31 | $65 |
| 2019-09-30 | $59 |
| 2019-06-30 | $69 |
| 2019-03-31 | $35 |
| 2018-12-31 | $71 |
| 2018-09-30 | $75 |
| 2018-06-30 | $65 |
| 2018-03-31 | $26 |
| 2017-12-31 | $-38 |
| 2017-09-30 | $97 |
| 2017-06-30 | $63 |
| 2017-03-31 | $36 |
| 2016-12-31 | $62 |
| 2016-09-30 | $54 |
| 2016-06-30 | $58 |
| 2016-03-31 | $42 |
| 2015-12-31 | $45 |
| 2015-09-30 | $55 |
| 2015-06-30 | $49 |
| 2015-03-31 | $40 |
| 2014-12-31 | $0 |
| 2014-09-30 | $43 |
| 2014-06-30 | $52 |
| 2014-03-31 | $35 |
| 2013-12-31 | $74 |
| 2013-09-30 | $41 |
| 2013-06-30 | $27 |
| 2013-03-31 | $32 |
| 2012-12-31 | $-13 |
| 2012-09-30 | $29 |
| 2012-06-30 | $34 |
| 2012-03-31 | $22 |
| 2011-12-31 | $-83 |
| 2011-09-30 | $28 |
| 2011-06-30 | $29 |
| 2011-03-31 | $27 |
| 2010-12-31 | $46 |
| 2010-09-30 | $27 |
| 2010-06-30 | $47 |
| 2010-03-31 | $20 |
| 2009-12-31 | $22 |
| 2009-09-30 | $13 |
| 2009-06-30 | $23 |
| 2009-03-31 | $15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.080B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.611B | 26.63 |
| CVS Health (CVS) | United States | $83.126B | 10.34 |
| Elevance Health (ELV) | United States | $66.200B | 8.90 |
| Cencora (COR) | United States | $55.265B | 18.41 |
| DiDi Global (DIDIY) | China | $26.074B | 27.70 |
| Labcorp Holdings (LH) | United States | $22.092B | 17.56 |
| Natera (NTRA) | United States | $20.748B | 0.00 |
| BioMerieux (BMXMF) | France | $17.652B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.860B | 0.00 |
| CochLear (CHEOY) | Australia | $13.234B | 0.00 |
| ICON (ICLR) | Ireland | $12.795B | 12.31 |
| Solventum (SOLV) | United States | $12.697B | 13.13 |
| Medpace Holdings (MEDP) | United States | $12.202B | 32.29 |
| Viatris (VTRS) | United States | $11.385B | 4.02 |
| Sonic Healthcare (SKHHY) | Australia | $8.961B | 0.00 |
| HealthEquity (HQY) | United States | $8.047B | 35.25 |
| Avantor (AVTR) | United States | $7.840B | 11.50 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.568B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.320B | 13.89 |
| Bausch + Lomb (BLCO) | Canada | $4.828B | 32.48 |
| Sotera Health (SHC) | United States | $3.965B | 22.17 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.82 |
| BrightSpring Health Services (BTSG) | United States | $3.681B | 28.08 |
| Surgery Partners (SGRY) | United States | $3.031B | 38.13 |
| GeneDx Holdings (WGS) | United States | $3.000B | 69.16 |
| Alignment Healthcare (ALHC) | United States | $2.873B | 0.00 |
| Concentras Parent (CON) | United States | $2.771B | 17.58 |
| Organon (OGN) | United States | $2.397B | 2.61 |
| Progyny (PGNY) | United States | $1.959B | 41.55 |
| Premier (PINC) | United States | $1.921B | 14.58 |
| Ardent Health (ARDT) | United States | $1.702B | 6.57 |
| PACS (PACS) | United States | $1.698B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.248B | 8.33 |
| GoodRx Holdings (GDRX) | United States | $1.239B | 20.41 |
| Teladoc Health (TDOC) | United States | $1.230B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.006B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Embecta (EMBC) | United States | $0.718B | 4.21 |
| AMN Healthcare Services Inc (AMN) | United States | $0.660B | 8.17 |
| CareDx (CDNA) | United States | $0.637B | 11.74 |
| Performant Healthcare (PHLT) | United States | $0.597B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.586B | 201.00 |
| So-Young (SY) | China | $0.506B | 0.00 |
| Omada Health (OMDA) | $0.490B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.488B | 7.39 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 10.37 |
| Sonida Senior Living (SNDA) | United States | $0.460B | 0.00 |
| SBC Medicals (SBC) | United States | $0.456B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.447B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.421B | 0.00 |
| Enhabit (EHAB) | United States | $0.386B | 25.40 |
| Oncology Institute (TOI) | United States | $0.382B | 0.00 |
| Agilon Health (AGL) | United States | $0.362B | 0.00 |
| LifeMD (LFMD) | United States | $0.323B | 0.00 |
| Beauty Health (SKIN) | United States | $0.238B | 0.00 |
| DocGo (DCGO) | United States | $0.160B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.106B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.093B | 0.00 |
| KindlyMD (NAKA) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| ModivCare (MODV) | United States | $0.035B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |